SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing intense selling pressure following a disappointing quarterly forecast, with investors openly questioning the company's long-term growth trajectory and leadership. The community is deeply divided between those calling for a structural 'value trap' exit and others aggressively buying the dip, citing its iconic global brand status as a potential catalyst for a future turnaround.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as investors weigh mixed sentiment regarding global expansion and beverage partnerships against ongoing concerns about financial performance and potential share dilution. The community remains deeply divided, with some betting on a short squeeze or a potential rebound linked to cannabis rescheduling, while others remain skeptical due to the stock's long-term downward trend.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently experiencing significant downward pressure as investors weigh cooling growth prospects against mounting legal risks stemming from recent court rulings on addictive product design. While some in the community are treating the rapid price pullback as a buying opportunity for long-term AI-driven upside, others are bracing for further volatility due to broader geopolitical tensions and institutional concerns about the company's liability outlook.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched NASA ETF is generating significant buzz as traders compare its exposure to space-sector heavyweights like SpaceX against other established funds. While many in the community are debating the fund's low initial assets under management and the validity of its holdings, momentum traders are actively discussing its potential for volatility and speculative growth.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors aggressively debate the company's aggressive Bitcoin acquisition strategy and the impact of recent dilution on shareholder value. Community sentiment is deeply polarized, with bulls viewing the stock as a prime leverage play on Bitcoin's long-term potential, while critics raise concerns over debt levels, the viability of its financing model, and the sustainability of its institutional treasury approach.

Ganymede

Ganymede is gaining attention as traders highlight its clean price structure and steady accumulation patterns. The community is actively discussing the potential for a breakout, viewing the current consolidation as a sign of underlying strength and controlled momentum.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors analyze the company's commercial execution following the launch of YARTEMLEA and weigh potential long-term value against continued short interest. The community is focused on upcoming financial reports and milestone updates as the primary catalysts to drive the share price toward its perceived intrinsic valuation.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as investors react to a significant debt-to-equity conversion by leadership, which has notably strengthened the company's balance sheet and bolstered confidence ahead of the upcoming earnings release. The community remains focused on the firm's expanding role in defense and aerospace supply chains, with intense discussion surrounding potential contract catalysts and the long-term viability of their additive manufacturing technology.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is facing significant market pressure following a year-over-year decline in first-quarter deliveries, with investors weighing the company's long-term pivot toward becoming a physical AI and robotics leader against near-term demand concerns. Community sentiment remains polarized, as many long-term shareholders continue to accumulate shares based on technological milestones like VLA 2.0 and global expansion, while others express frustration over the stock's persistent underperformance and relative weakness compared to its Chinese EV peers.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is currently trading in the spotlight as investors brace for the upcoming March delivery report and first-quarter figures, with the community closely tracking whether recent sales momentum and new model launches can drive a break above key resistance levels. Discussions remain polarized, pitting bulls who anticipate a strong growth trajectory and potential short squeeze against bears who express continued skepticism regarding long-term profitability and historical price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5%

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 13th, there was short interest totaling 8,281,198 shares, a drop of 18.5% from the February 26th total of 10,159,609 shares. Approximately 2.8% of the shares of the...

Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Standard BioTools from a "sell" rating to a "hold" rating in a report on Saturday...

Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC

Mak Capital One LLC grew its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 184.6% during the third quarter, according to its most recent Form 13F filing with the...

Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen

Wall Street Zen cut shares of Standard BioTools from a "hold" rating to a "sell" rating in a report on Sunday...

Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Standard BioTools from a "sell" rating to a "hold" rating in a research note on Saturday...

Standard BioTools (NASDAQ:LAB) Announces Earnings Results

Standard BioTools (NASDAQ:LAB - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts' consensus...

Standard BioTools (LAB) Expected to Announce Quarterly Earnings on Tuesday

Standard BioTools (NASDAQ:LAB) will be releasing its Q4 2025 earnings after the market closes on Tuesday, February 24. (View Earnings Report at...

Sumitomo Mitsui Trust Group Inc. Sells 773,708 Shares of Standard BioTools Inc. $LAB

Sumitomo Mitsui Trust Group Inc. cut its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 12.5% during the 3rd quarter, according to its most recent disclosure with the...

Standard BioTools (NASDAQ:LAB) Shares Gap Up - Should You Buy?

Standard BioTools (NASDAQ:LAB) Shares Gap Up - What's Next...

Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% - What's Next?

Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% - Here's What Happened...

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.

Standard BioTools Inc

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.04	--	--	N/A
Q4 '25	-$0.05	$0.04	174.17%	BEAT
Q3 '25	-$0.04	-$0.09	-107.69%	MISSED
Q2 '25	-$0.07	-$0.05	25.07%	BEAT
Q1 '25	-$0.05	-$0.07	-27.27%	MISSED

LAB
Standard BioTools Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest LAB News

LABStandard BioTools Inc